Literature DB >> 30033101

Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes.

Kyung-Ho Min1, Won-Mo Yang1, Wan Lee2.   

Abstract

The excessive intake of saturated fatty acids (SFA) causes obesity and liver steatosis, which are major risk factors for insulin resistance and type 2 diabetes. Although the expression of certain microRNAs (miRNAs) targeting the insulin signaling molecules are regulated aberrantly in SFA-induced obesity, their implications on hepatic insulin resistance are largely unknown. This study examined the associations of miR-424-5p, which is induced by SFA, with the development of insulin resistance. SFA palmitate (PA)-treated HepG2 cells and high fat diet (HFD)-induced obese mouse livers showed an impairment of insulin signaling due to a significant decrease in INSR and IRS-1 expression. Based on expression profiling and qRT-PCR analysis, miR-424-5p, which presumably targets the 3'UTR of INSR, was upregulated in both PA-treated HepG2 cells and the liver of HFD-fed mice. miR-424-5p was found to target the 3'UTR of INSR directly and downregulated INSR expression at the post-transcriptional step. Furthermore, the overexpression of miR-424-5p suppressed INSR expression significantly, leading to impaired insulin signaling and glycogen synthesis in hepatocytes. A novel mechanism for how SFA-induced miR-424-5p impairs insulin signaling through the targeting of INSR is reported. In addition, the crucial role and underlying mechanism of miR-424-5p in the obesity-induced hepatic insulin resistance is explained.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Insulin resistance; Obesity; Palmitate; Saturated fatty acid; miR-424–5p; microRNA

Mesh:

Substances:

Year:  2018        PMID: 30033101     DOI: 10.1016/j.bbrc.2018.07.084

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview.

Authors:  Pads Palihaderu; Bilm Mendis; Jmkjk Premarathne; Wkrr Dias; Swee Keong Yeap; Wan Yong Ho; A S Dissanayake; I H Rajapakse; P Karunanayake; U Senarath; D A Satharasinghe
Journal:  Epigenet Insights       Date:  2022-10-15

2.  The Yin and Yang function of microRNAs in insulin signalling and cancer.

Authors:  Juanhong Liu; Feng Liu
Journal:  RNA Biol       Date:  2020-08-13       Impact factor: 4.652

3.  NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells.

Authors:  Yinfang Wang; Xiaohong Wan; Yilong Hao; Yuanyuan Zhao; Lanlan Du; Yitong Huang; Zongjun Liu; Ying Wang; Nanping Wang; Peng Zhang
Journal:  Cell Commun Signal       Date:  2019-07-17       Impact factor: 5.712

Review 4.  Centennial Review: Metabolic microRNA - shifting gears in the regulation of metabolic pathways in poultry.

Authors:  Julie A Hicks; Hsiao-Ching Liu
Journal:  Poult Sci       Date:  2020-11-28       Impact factor: 3.352

5.  Circulating microRNAs are associated with variability in fasting blood glucose over 12-months and target pathways related to type 2 diabetes: A pilot study.

Authors:  Elena Flowers; Isabel E Allen; Alka M Kanaya; Bradley E Aouizerat
Journal:  Diab Vasc Dis Res       Date:  2021 Nov-Dec       Impact factor: 3.291

Review 6.  MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review.

Authors:  Lisa Dowling; Ankita Duseja; Tatiane Vilaca; Jennifer S Walsh; Katarzyna Goljanek-Whysall
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-04       Impact factor: 12.910

7.  Differential expression of novel MicroRNAs from developing fetal heart of Gallus gallus domesticus implies a role in cardiac development.

Authors:  Sharad Saxena; Priyanka Mathur; Vaibhav Shukla; Vibha Rani
Journal:  Mol Cell Biochem       Date:  2019-09-07       Impact factor: 3.396

Review 8.  Transcriptional Regulation of INSR, the Insulin Receptor Gene.

Authors:  Sandhya Payankaulam; Ana-Maria Raicu; David N Arnosti
Journal:  Genes (Basel)       Date:  2019-11-29       Impact factor: 4.096

9.  miR-322/-503 rescues myoblast defects in myotonic dystrophy type 1 cell model by targeting CUG repeats.

Authors:  Xiaopeng Shen; Feng Xu; Meng Li; Shen Wu; Jingyi Zhang; Ao Wang; Lei Xu; Yu Liu; Guoping Zhu
Journal:  Cell Death Dis       Date:  2020-10-22       Impact factor: 8.469

Review 10.  Insulin action at a molecular level - 100 years of progress.

Authors:  Morris F White; C Ronald Kahn
Journal:  Mol Metab       Date:  2021-07-15       Impact factor: 8.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.